Yungblud’s 2026 Australian tour dates will move ahead as scheduled, even as the U.K. singer halts all remaining performances for the rest of 2025 due to medical advice.
The Doncaster-born artist revealed over the weekend that recent vocal and blood test results prompted doctors to suspend his touring commitments through the end of the year.
The announcement raised questions about his planned Australian run, but Frontier Touring confirms the January shows are unaffected. “Yungblud’s remaining U.S., Mexico and Latin America shows have been cancelled through to the end of 2025, per his statement. The Australian dates in 2026 remain as scheduled,” the promoter said in a message to media.
“We’re looking forward to seeing Yungblud in January and extend our best wishes while he takes some time to rest and recover.”
Posting to Instagram on Nov. 16, Yungblud told fans he had undergone routine tests after returning home from tour, receiving results that required an immediate break. “My voice and blood tests have raised some concerns,” he wrote. “My doctor has ordered me to take a break from touring until the end of the year.”
The singer, who has built a reputation for intensive touring and high-energy performances, acknowledged that slowing down is unfamiliar territory. “It is in my nature to run and run until I run myself to the ground,” he wrote. “But this time I’ve been told I have to take it seriously… I don’t want to do any lasting damage to myself.”
Yungblud’s upcoming Australian dates mark his largest headline shows in the region to date. The tour begins Jan. 10 at Qudos Bank Arena in Sydney, followed by outdoor and arena stops in Melbourne, Adelaide, Brisbane and Perth. A second Brisbane show on Jan. 18 has been added due to demand.
The January run arrives as Yungblud prepares the next phase of his release cycle, following a year marked by festival appearances, international touring and new music previews throughout Europe and North America.
This story originally appeared on Billboard
